medigraphic.com
ISSN 2594-1526 (Electronic)
Antes Revista del Instituto Nacional de Enfermedades Respiratorias

 Ver anteriores al 2010

2014, Number 3

<< Back Next >>

Neumol Cir Torax 2014; 73 (3)

Impact of smoking and COPD on brain functioning

Noé-Díaz V, García-Gómez L, Sansores RH, Ramírez-Venegas A

Language: Spanish
References: 70
Page: 196-204
PDF size: 233.87 Kb.


ABSTRACT

There are several conditions and factors that may have an impact on brain functioning due to physiological changes in brain structures. In clinical practice, respiratory disease, including smoking and chronic obstructive pulmonary disease (COPD) are not always approached from a neuropsychological angle. With other comorbidities and at different levels, smoking and COPD foster a series of physiological and neuropsychological changes that have an impact on quality of life and functioning of patients. This review summarizes critical aspects of cognitive functioning and respiratory diseases.


REFERENCES

  1. Instituto Nacional de Estadística, Geografía e Informática. A propósito del día del tabaco. México: INEGI, 2008. Fecha de consulta: julio, 2014. Disponible en: www.inegi.org.mx/inegi/contenidos/espanol/prensa/.../tabaco05.pdf.

  2. World Health Organization. Tabaquismo. 2011. Fecha de consulta: julio, 2014. Disponible en: http://www.who.int/topics/tobacco/es/

  3. Sansores MR, Ramírez-Venegas A. Enfermedad pulmonar obstructiva crónica y la celebración de su primer Día Mundial. Rev Inst Nal Enf Resp Mex 2002; 15(4):199-200.

  4. Sansores R, Ramírez-Venegas A, Espinosa M, Sandoval R. Tratamientos para dejar de fumar, disponibles en México. Salud Publica Mex 2002;44 supl 1):S116-S124. http://dx.doi.org/10.1590/S0036-36342002000700017.

  5. Secretaría de Salud. Programa de Acción. Adiciones. Tabaquismo. México, 2001. Fecha de consulta: julio, 2014. Disponible en: http://www.salud.gob.mx/unidades/cdi/documentos/tabaquismo.pdf.

  6. Murray CJ, Lopez AD. Measuring the global burden of disease. N Engl J Med 2013;369(5):448-457.doi:10.1056/NEJMra1201534.

  7. Paul RH, Brickman AM, Cohen RA, et al. Cognitive status of young and older cigarette smokers: data from the international brain database. J Clin Neurosci 2006;13(4):457-465.

  8. Jasinska AJ, Zorick T, Brody AL, Stein EA. Dual role of nicotine in addiction and cognition: a review of neuroimaging studies in humans. Neuropharmacology 2014;84:111-122. doi:10.1016/j.neuropharm.2013.02.015.

  9. Sansores RH, Ramírez-Venegas A, Hernández-Zenteno R, Mayar-Maya ME, Pérez-Bautista OG, Velázquez Uncal M. Prevalence and diagnosis of chronic obstructive pulmonary disease among smokers at risk. A comparative study of case-finding vs. screening strategies. Respir Med 2013;107(4):580-586. doi: 10.1016/j.rmed.2012.12.010.

  10. Guías para el Diagnóstico y Tratamiento de la Enfermedad Pulmonar Obstructiva Crónica. Derivadas del Cuarto Consenso Mexicano para el Diagnóstico y Tratamiento de la EPOC. Neumol Cir Torax 2012;71(1 supl):S8-S89.

  11. Benowitz NL. Nicotine addiction. N Engl J Med 2010;362(24):2295-2303. doi: 10.1056/NEJMra0809890.

  12. American Psychiatric Association. DSM-IV-TR. Manual diagnóstico y estadístico de los trastornos mentales. Barcelona: Masson; 2002.p.181-199.

  13. Volkow ND, Baler RD. Addiction science: Uncovering neurobiological complexity. Neuropharmacology 2014;76 Pt B:235-249. doi: 10.1016/j.neuropharm.2013.05.007

  14. Baler RD, Volkow ND. Drug addiction: the neurobiology of disrupted self-control. Trends Mol Med 2006;12(12):559-566. doi:10.1016/j.molmed.2006.10.005.

  15. Muñoz MÁ, Sanjuan R, Fernández-Santaella MC, Vila J, Montoya P. Neuropsychological aspects of nicotine craving. Adicciones 2011;23(2):111-123.

  16. Volkow ND, Wang GJ, Fowler JS, Tomasi D. Addiction circuitry in the human brain. Annu Rev Pharmacol Toxicol 2012;52:321-336. doi:10.1146/annurevpharmtox-010611-134625.

  17. Spronk DB, van Wel JH, Ramaekersc JG, Verkes RJ. Characterizing the cognitive effects of cocaine: a comprehensive review. Neurosci Biobehav Rev 2013;37(8):1838-1859. doi: 10.1016/j.neubiorev.2013.07.003.

  18. Zhang X, Salmeron BJ, Ross TJ, et al. Anatomical differences and network characteristics underlying smoking cue reactivity. Neuroimage 2011;54(1):131-141. doi: 10.1016/j.neuroimage.2010.07.063.

  19. Durazzo TC, Meyerthoff DJ, Nixon SJ. Chronic cigarette smoking: implications for neurocognition and brain neurobiology. Int J Environ Res Public Health 2010;7(10):3760-3791. doi: 10.3390/ijerph7103760.

  20. Rusted JM, Sawyer R, Jones C, Trawley SL, Marchant NL. Positive effects of nicotine on cognition: the deployment of attention for prospective memory. Psychopharmacology (Berl) 2009;202(1-3):93-102.doi:10.1007/s00213-008-1320-7.

  21. Mansvelder HD, van Aerde KI, Couey JJ, Brussaard A. Nicotinic modulation of neuronal networks: from receptors to cognition. Psychopharmacology (Berl) 2006;184(3-4):292-305.

  22. Ríčný J. Overlooked Alzheimer’s smoking gun? Neurochem Res 2013;38(9): 1774-1776. doi10.1007/s11064-013-1086-0.

  23. Almeida OP, Garrido GJ, Alfonso H, et al. 24-month effect of smoking cessation on cognitive function and brain structure in later life. Neuroimage 2011;55(4):1480-1489. doi: 10.1016/j.neuroimage.2011.01.063.

  24. Fried PA, Watkinson B, Gray R. Neurocognitive consequences of cigarette smoking in young adults--a comparison with pre-drug performance. Neurotoxicol Teratol 2006;28(4):517-525.

  25. Iniciativa Global para la Enfermedad Pulmonar Obstructiva Crónica. Guía para el Diagnóstico, Tratamiento y Prevención de la EPOC. Una Guía para profesionales sanitarios. EUA, 2001.p.6-10. Fecha de consulta: julio, 2014. Disponible en: http://www.fisiorespiracion.es/gold.pdf

  26. Mendoza JE, Foundas AL. The vascular system. In: Clinical neuroanatomy: A neurobehavioral approach. New York: Springer;2008.p.520-523.

  27. Consenso Mexicano de EPOC. Intervenciones prioritarias. Neumol Cir Torax 2007;66(sup 2):S26-S31.

  28. Areza-Fegyveres R, Kairalla RA, Carvalho CR, Nitrini R. Cognition and chronic hypoxia in pulmonary diseases. Dement Neuropsychol 2010;4(1):14-22.

  29. Torre-Bouscoulet T, Vázquez-García JC, Pérez-Padilla R. Oxigenoterapia crónica domiciliaria en altitudes moderadas. Un enorme reto en salud. Neumol Cir Torax 2011;70(3):149-151.

  30. Vargas-Domínguez C, Gochicoa-Rangel L, Velázquez-Uncal M, et al. Pruebas de función respiratoria, ¿cuál y a quién? Neumol Cir Torax 2011;70(2):101-117.

  31. Dodd JW, Getov SV, Jones PW. Cognitive function in COPD. Eur Respir J 2010;35(4):913-922. doi: 10.1183/09031936.00125109.

  32. Kuwaki, T. Hypothalamic modulation of breathing. Adv Exp Med Biol 2010;669:243-247. doi: 10.1007/978-1-4419-5692-7_49.

  33. Patel AJ, Honoré E. Molecular physiology of oxygen-sensitive potassium channels. Eur Respir J 2001;18(1):221-227.

  34. Virués-Ortega J, Garrido E, Javierre C, Rivero PD. Funcionamiento neuropsicológico bajo condiciones de hipoxia aguda y crónica asociada a la altitud. Arch Biol Andina 2008;14(1):40-50.

  35. Kawasaki K, Traynelis SF, Dingledine R. Different responses of CA1 and CA3 regions to hypoxia in rat hippocampal slice. Neurophysiol 1990;63(3):385-394.

  36. Di Paola M, Caltagirone C, Fadda L, Sabatini U, Serra L, Carlesimo GA. Hippocampal atrophy is the critical brain change in patients with hypoxic amnesia. Hippocampus 2008;18(7):719-728. doi: 10.1002/hipo.20432.

  37. Hopkins RO, Bigler, ED. Hypoxic and anoxic conditions of the CNS. In: Morgan J, Ricker J, editors. Textbook of clinical neuropsychology. New York, EUA: Taylor & Francis; 2008.p.521-535.

  38. Shim TS, Lee JH, Kim SY, et al. Cerebral metabolic abnormalities in COPD patients detected by localized proton magnetic resonance spectroscopy. Chest 2001;120(5):1506-1513.

  39. Morgan B. Vascular consequences of intermittent hypoxia. In: Roach RC, Wagner PD, Hackett PH, editors. Hypoxia and the circulation. Advances in experimental medicine and biology. New York, EUA: Springer; 2007.p.51-67.

  40. Singh B, Parsaik AK, Mielke MM, et al. Chronic obstructive pulmonary disease and association with mild cognitive impairment: the Mayo Clinic Study of Aging. Mayo Clinic Pro 2013;88(11):1222-1230. doi: 10.1016/j.mayocp.2013.08.012.

  41. Tulek B, Atalay NB, Yildirim G, Kanat F, Süerdem M. Cognitive function in chronic obstructive pulmonary disease: relationship to global initiative for chronic obstructive lung disease 2011 categories. Respirology 2014;19(6):873-880.doi: 10.1111/resp.12333.

  42. Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12(3):189-198.

  43. Ardila A, Ostrosky F. Guía para el diagnóstico neuropsicológico. 2012,127-152. Fecha de consulta: julio, 2014. Disponible en: http://www.ineuro.cucba.udg.mx/libros/bv_guia_para_el_diagnostico_neuropsicologico.pdf.

  44. Lezak M. Neuropsychological assessment. 4th ed. New York: Oxford University Press; 2004.p.714.

  45. Kozora E, Emery CF, Ellison MC, Wamboldt FS, Díaz PT, Make P. Improved neurobehavioral functioning in emphysema patients following lung volume reduction surgery compared with medical therapy. Chest 2005;128(4):2653-2663.

  46. Kozora E, Emery CF, Zhang L, Hoth KF, Murphy J, Make B; National Emphysema Treatment Trial Research Group. Sequential cognitive skills in emphysema patients following lung volume reduction surgery: a 2-year longitudinal study. J Cardiopulm Rehabil Prev 2011;31(6):386-391. doi: 10.1097/HCR.0b013e3182343bc8.

  47. Dal Negro RW, Bonadiman L, Tognella S, Bricolo FP, Turco P. Extent and prevalence of cognitive dysfunction
in chronic obstructive pulmonary disease, chronic non-obstructive bronchitis, and in asymptomatic smokers, compared to normal reference values. Int J Chron Obstruct Pulmon Dis 2014;9:675-683. doi: 10.2147/COPD.S63485.

  48. Ortapamuk H, Naldoken S. Brain perfusion abnormalities in chronic obstructive pulmonary disease: comparison with cognitive impairment. Ann Nucl Med 2006;20(2):99-106.

  49. Crews WD, Jefferson AL, Bolduc T, et al. Neuropsychological dysfunction in patients suffering from end-stage chronic obstructive pulmonary disease. Arch Clin Neuropsychol 2001;16(7):643-652.

  50. Borson S, Scanlan J, Friedman S, et al. Modeling the impact of COPD on the brain. Int J Chron Obstruct Pulmon Dis 2008;3(3):429-434.

  51. Kent BD, Mitchell PD, McNicholas WT. Hypoxemia in patients with COPD: causes, effects, and disease progression. Int J Chron Obstruct Pulmon Dis 2011;6:199-208. doi: 10.2147/COPD.S10611.

  52. Tombaugh TN. Trail Making Test A and B: Normative data stratified by age and education. Arch Clin Neuropsychol 2004;19(2):203-214.

  53. Tombaugh TN, Kazak J, Rees L. Normative data stratified by age and education for two measures of verbal fluency: FAS and animal naming. Arch Clin Neuropsychol 1999;14(2):167-177.

  54. Liesker JJ, Postma DS, Beukema RJ, et al. Cognitive performance in patients with COPD. Respir Med 2004;98(4):351-356.

  55. De Carolis A, Giubilei F, Caselli G, et al. Chronic obstructive pulmonary disease is associated with altered neuropsychological performance in young adults. Dement Geriatr Cogn Dis Extra 2011;1(1):402-408. doi: 10.1159/000333079.

  56. Grant I, Heaton RK, McSweeney AJ, Adams KM, Timms RM. Brain dysfunction in COPD. Chest 1980;77(2 Suppl):S308-S309.

  57. Dodd JW, Chung AW, van den Broek MD, Barrick TR, Charlton RA, Jones PW. Brain structure and function in chronic obstructive pulmonary disease: a multimodal cranial magnetic resonance imaging study. Am J Respir Crit Care Med 2012;186(3):240-245. doi:10.1164/rccm.201202-0355OC.

  58. Kaptein AA, Scharloo M, Fischer MJ, et al. 50 years of psychological research on patients with COPD- road to ruin or highway to heaven? Respir Med 2009;103(1):3-11. doi: 10.1016/j.rmed.2008.08.019.

  59. Warrington JP, Ashpole N, Csiszar A, Lee YW, Ungvari Z, Sonntag WE. Whole brain radiation-induced vascular cognitive impairment: mechanisms and implications. J Vasc Res 2013;50(6):445-457.doi:10.1159/000354227.

  60. Schega L, Peter B, Törpel A, Mutschler H, Isermann B, Hamacher D. Effects of intermittent hypoxia on cognitive performance and quality of life in elderly adults: a pilot study. Gerontology 2013;59(4):316-323.doi:10.1159/000350927.

  61. Portellano JA. Introducción a la neuropsicología. Madrid: McGrawHill; 2005.p.233-239.

  62. Emery CF, Green MR, Suh S. Neuropsychiatric function in chronic lung disease: the role of pulmonary rehabilitation. Respir Care 2008;53(9):1208-1216.

  63. Etnier J, Johnston R, Dagenbach D, Pollard RJ, Rejeski WJ, Berry M. The relationship among pulmonary function, aerobic fitness, and cognitive functioning in older COPD. Chest 1999;116(4):953-960.

  64. Antonelli-Incalzi R, Corsonello A, Pedone C. Drawing impairment predicts mortality in severe COPD. Chest 2006;130(6):1687-1694.

  65. Sakurai Y, Kanazawa I. Acute effects of cigarettes in non-deprived smokers on memory, calculation and executive functions. Hum Psychopharmacol 2002; 17(7):369-373.doi:10.1002/hup.424.

  66. Yakir A, Rigbi A, Kanyas K, et al. Why do young women smoke? III. Attention and impulsivity as neurocognitive predisposing factors. Eur Neuropsychopharmacol 2007;17(5):339-351.

  67. Dodd JW, Charlton RA, van den Broek MD, Jones PW. Cognitive dysfunction in patients hospitalized with acute exacerbation of COPD. Chest 2013;144(1):119-127. doi:10.1378/chest.12-2099.

  68. Li J, Huang Y, Fei GH. The evaluation of cognitive impairment and relevant factors in patients with chronic obstructive pulmonary disease. Respiration 2013;85(2):98-105.doi:10.1159/000342970.

  69. Chang SS, Chen S, McAvay GJ, Tinetti ME. Effect of coexisting chronic obstructive pulmonary disease and cognitive impairment on health outcomes in older adults. J Am Geriatr Soc 2012;60(10):1839-1846.doi:10.1111/j.1532-5415.2012.04171.

  70. Pereira ED, Viana CS, Taunay TC, Sales PU, Lima JW, Holanda MA. Improvement of cognitive function after a three-month pulmonary rehabilitation program for COPD patients. Lung 2011;189(4):279-285.doi:10.1007/s00408-011-9303-6.




2020     |     www.medigraphic.com